KLF8 Antibodies

Santa Cruz Biotechnology features a diverse variety of KLF8 monoclonal antibodies for investigating KLF8 in various biological processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KLF8, or Krüppel-like factor 8, is a transcription factor that plays a critical role in cell proliferation, differentiation, and survival. Research has shown KLF8's involvement in epithelial-mesenchymal transition (EMT) and cancer progression, making it a significant focus in cancer biology and developmental studies. Understanding KLF8 function can reveal potential therapeutic targets for diseases characterized by aberrant cell growth and migration. Researchers can utilize specific KLF8 monoclonal antibodies conjugated with horseradish peroxidase (HRP), phycoerythrin (PE), or fluorescein isothiocyanate (FITC) for enhanced detection flexibility. Investigating KLF8 expression patterns helps illuminate its role in normal development and disease states. Current studies continue to uncover new functions of KLF8 in cellular signaling pathways. Santa Cruz Biotechnology monoclonal antibodies for KLF8 enable researchers worldwide to advance scientific understanding of this important transcription factor.